cathie wood's ARK trades highlight major Alibaba and Reddit stock moves

Cathie Wood's ARK ETFs recently executed significant portfolio adjustments, notably acquiring $26.1 million in Alibaba Group Holding Ltd (BABA) shares across ARKK, ARKW, and ARKF. Concurrently, ARK divested $8.1 million from Reddit Inc (RDDT) and continued accumulating CRISPR Therapeutics AG (CRSP) with a $2.1 million purchase. The fund also strategically shifted its healthcare exposure by buying Tempus AI Inc (TEM) while selling Exact Sciences Corp (EXAS), alongside further reducing its stake in Iridium Communications Inc (IRDM), reflecting a dynamic investment strategy across technology and biotech sectors.

Analysis

Cathie Wood's ARK ETFs executed significant portfolio adjustments on November 11, 2025, with a notable acquisition of 157,731 shares of Alibaba Group Holding Ltd (BABA) valued at $26.17 million, spread across ARKK, ARKW, and ARKF. This substantial investment signals a strong conviction in BABA, aligning with a positive per-ticker sentiment score of 0.6. Concurrently, ARK divested 40,000 shares of Reddit Inc (RDDT) for $8.17 million, indicating a significant reduction in exposure and a negative per-ticker sentiment of -0.6.

The fund continued its accumulation in CRISPR Therapeutics AG (CRSP), acquiring 39,250 shares worth $2.14 million, reinforcing a positive stance (sentiment 0.6) and a recent buying trend. In the healthcare sector, ARK strategically shifted focus by purchasing 17,654 shares of Tempus AI Inc (TEM) for $1.27 million while selling 108,664 shares of Exact Sciences Corp (EXAS) for $7.23 million, reflecting a preference for TEM (sentiment 0.5) over EXAS (sentiment -0.5).

Further divestments included 192,986 shares of Iridium Communications Inc (IRDM) for $3.18 million, continuing a recent selling trend (sentiment -0.6), and a smaller sale of 789 shares of Tesla Inc (TSLA) for $351,286 (sentiment -0.3). These trades collectively underscore ARK's dynamic investment strategy, balancing significant acquisitions in specific technology and biotech names with strategic divestments in others, contributing to an overall market impact score of 0.3.

Key Decisions for Investors

• Investors should note ARK's significant conviction in Alibaba (BABA) and CRISPR Therapeutics (CRSP), potentially signaling growth opportunities in these names.
• Investors may consider reviewing their exposure to Reddit (RDDT), Exact Sciences (EXAS), and Iridium Communications (IRDM) given ARK's recent divestments.
• These portfolio adjustments highlight ARK's active management and sector rotation, particularly towards specific technology and biotech innovators, which warrants further due diligence.